Vedolizumab IV
Vedolizumab-4020
Approved small_molecule active
Quick answer
Vedolizumab IV for Ulcerative Colitis is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 4 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Ulcerative Colitis
- Phase
- Approved
- Modality
- small_molecule
- Status
- active